Shire's Lialda Launch For Ulcerative Colitis Will Focus On Dosing Convenience
This article was originally published in The Pink Sheet Daily
Executive Summary
Shire is planning an sNDA for a remission maintenance claim within two years, the firm tells "The Pink Sheet" DAILY.